Effect of Herbal Formulation on Thrombocytes Count

Thrombocytopenia Clinical Trial

Official title: Effect of Herbal Formulation on Karika Syrup on Thrombocytes Count

Status Recruiting

Clinical Trial Summary

Effect of Herbal Formulation Karika Syrup on Thrombocyte Count.

Clinical Trial Description

In this study, we will evaluate the effect of Herbal Formulation Karika (composed of Carica papaya leaf extract and Tinosporacordifolia) on Complete Blood Count, specifically on Platelet Count. Low Platelet Count is highly observant during multiple diseases namely dengue, malaria, typhoid, chikungunya, viral infections, and other Diseases. The proposed study is a randomized, open, prospective, multicenter clinical trial. Extracts found in Karika syrup are beneficial in escalating platelet count, and also have anti-inflammatory and antipyretic activity. The therapeutic indication of Karika is proven through this clinical study in patients with low platelet count associated with dengue, typhoid, malaria, viral fever, and chikungunya fever. Dengue is a tropical disease caused by the RNA virus which resides in mosquitoes. Symptoms include high-grade fever, visual disturbances, pain in the eyes and head, nausea, vomiting, musculoskeletal pain, stiffness of joints, mild to moderate and severe bleeding, and sometimes puerperal rash appearing on the skin due to a deficiency of thrombocytes. The Chikungunya virus is spread by the bite of an infected mosquito. Typhoid is caused by Salmonella typhi a bacterium. Typhoid fever symptoms are seen widely in the human body that may observe from relatively minor cases of diarrhea with low-grade fever to high-grade fever and profound diarrhea with involvement of multiple systems.1 ;

Related Conditions & MeSH terms

• Thrombocytopenia

• NCT number: NCT05563064
• Study type: Interventional
• Source: Shifa Ul Mulk Memorial Hospital
• Status: Recruiting
• Phase: Phase 3
• Start date: January 1, 2021
• Completion date: January 1, 2023